SunGlowInnovations

SunGlow Innovations

Science

How local oxidative reactions, image guidance and containment come together in the CDX-101 research program.

CDX-101 MECHANISM RESEARCH

Local oxidation and secondary ischemia

Direct contact and the proposed downstream ischemic effect A light warm-gray contact zone overlaps a red tumor microvessel. A dashed connection leads from the possible vessel injury to a downstream tissue zone with potentially reduced perfusion. Direct contact zone Downstream zone
Tumor microvesselChlorine dioxide solutionDirect contact zoneProposed perfusion loss
  1. 1
    Experimental observation

    Direct contact

    Tissue changes were documented at the site of contact in laboratory experiments. The sponsor attributes this local effect to oxidation.

  2. 2
    Observation and hypothesis

    Microvessel at the contact zone

    Vascular injury was observed in an animal model. The sponsor hypothesizes that injury to tumor microvessels can reduce flow beyond the contact zone.

  3. 3
    Hypothesis

    Downstream ischemia

    Reduced perfusion could contribute to tissue injury outside the direct contact zone. The proposed study treats perfusion measures as exploratory.

Schematic. The red vessels show the proposed path from local contact to a downstream perfusion change. The figure contains no clinical imaging or perfusion measurements.

12 technical features

The features follow Table 2-1 of the IND Investigator’s Brochure and Table 4-1 of the technical rationale. Expand each item to see how the observations support it and to read the related studies and case records.

01Two local effectsObservation and hypothesis

The sponsor proposes direct oxidation in tissue exposed to the solution and a second effect mediated by the tumor microvasculature.

What was recorded
Laboratory tissue changes and vascular injury were reported. In selected human and animal cases, the estimated extent of necrosis exceeded the delivered liquid volume.
How the evidence supports this feature
The liver experiments document a local contact effect, and the mouse vascular model shows that injury after vascular exposure can involve downstream tissue. In canine mammary tumor case P19, the visible contact zone on day 2 was smaller than the main lesion, which separated as a whole on day 9. These observations motivate testing the secondary ischemia hypothesis by comparing distribution, perfusion and later necrosis within the same lesion.
Next assessment focus
Compare contact distribution, perfusion change and necrosis in the same lesion to assess the contribution of downstream ischemia.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
02Rapid self-limitation and a stable reaction boundaryExperimental observation

The sponsor links rapid consumption at the contact site to a bounded reaction.

What was recorded
In the whole-blood experiment, a reaction boundary was described at about one minute with no visible expansion at 60 minutes. Ex vivo liver experiments also showed a bounded reaction.
How the evidence supports this feature
Whole blood developed a visible reaction boundary in about a minute, and the recorded zone remained stable during observation. Fresh and freeze-thawed liver also showed similar, sharply bounded zones. The agreement across these preparations supports a rapid transition to a stable local reaction under the tested conditions. The clinical plan evaluates distribution and blood reaction products separately.
Next assessment focus
Use the experimental reaction boundary as a starting point and assess distribution and exposure in participants with real-time imaging and blood tests.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
03Short intravascular propagationExperimental observation

The original materials describe a localized pattern of injury following vascular exposure in an animal model.

What was recorded
In the mouse tail-vein model, injury was described around the accessed vessel and its downstream territory.
How the evidence supports this feature
The mouse tail-vein observations localized visible injury to the exposed vascular region and adjacent downstream tissue. They support a spatially bounded pattern in that model and document why non-target exposure matters. The study tracks visible spread beyond the lesion and subsequent tissue injury as separate safety observations.
Next assessment focus
Use delivery imaging, out-of-lesion distribution records and safety follow-up to assess non-target tissue injury.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
04Hemostasis and acute edema observationsHistorical observation

The original tables pair reports of bleeding cessation with observations on early swelling.

What was recorded
Selected historical reports described bleeding cessation or no visible early swelling during limited observation.
How the evidence supports this feature
Bleeding stopped at the treated site in human breast tumor case H1 and in feline squamous cell carcinoma case P10. Canine case P6 separately recorded no swelling on day 1. These case records support tracking hemostasis and early swelling as distinct local outcomes, with the time of onset and duration recorded for each.
Next assessment focus
Record bleeding, swelling and pain at standard time points to quantify the magnitude and duration of symptom changes.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
05Intraprocedural visual changesHistorical observation

Directly visible lesions provided an early visual readout in the historical records.

What was recorded
In a four-dog oral and tongue tumor image series, surface changes were documented about 15–20 minutes after delivery.
How the evidence supports this feature
The canine oral and tongue tumor series captured visible surface changes during the procedure. Surgical observation in P18 also recorded persistent discoloration in the exposed area. Their timing makes surface appearance a useful procedural observation in lesions that can be seen directly. Follow-up imaging provides a separate assessment of tissue viability.
Next assessment focus
Compare visible surface changes with perfusion imaging and the later assessment of tissue viability.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
06Real-time distribution imaging and containmentHistorical observation

Imaging was used to observe the visible distribution front and its relationship to the lesion boundary.

What was recorded
The historical material reports a visible ultrasound front in about 1–2 seconds and bounded contrast-enhanced CT distributions in selected cases.
How the evidence supports this feature
Historical ultrasound records captured a visible front as distribution occurred. In P12, CT showed the distribution and identified an area without visible coverage. Together these observations support monitoring where the solution is visible relative to the lesion boundary during the procedure. Follow-up contrast imaging answers the separate question of how much tissue became non-viable.
Next assessment focus
Record visible distribution during delivery and necrosis on follow-up separately, then compare the two measures.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
07Local effects after repeat sessionsHistorical observation

The sponsor describes repeat local effects in residual or recurrent lesions.

What was recorded
Selected human and companion-animal records reported further local changes after subsequent sessions.
How the evidence supports this feature
In canine oral sarcoma case P4, local changes were recorded after both sessions. Case P15 also recorded necrosis during a course of three sessions in one month, with fever documented after the first session. Session-by-session records support evaluating whether the local effect recurs and tracking adverse events across the course.
Next assessment focus
Compare local response and adverse events across early and later sessions to assess repeatability and cumulative safety.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
08Large or irregular lesionsHistorical observation

The sponsor describes assessing different regions of complex lesions separately or across sessions.

What was recorded
The historical series includes selected cases involving large lesions in humans and companion animals.
How the evidence supports this feature
CT showed several distinct distribution zones in canine soft-tissue sarcoma case P6, and the mass later collapsed markedly. In the large chest-wall mass P7, the contour changed and the record showed no measurable shrinkage at day 12. The different findings support assessing coverage and subsequent response by region, with lesion size and anatomy documented alongside the findings.
Next assessment focus
Record coverage, local response and safety by lesion size and anatomical location to define the range of application.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
09Multiple lesionsHistorical observation

The source distinguishes assessment of individual lesions, groups of lesions and staged sessions.

What was recorded
Selected companion-animal records document multiple lesions evaluated during one session or across a course.
How the evidence supports this feature
Ultrasound-guided delivery was recorded in several larger masses in canine multicentric lymphoma case P20. In human breast cancer case H10, two treated sites had a documented local response and follow-up, with new nodes recorded outside the treated field. The records support the feasibility of working with more than one lesion and show the value of tracking treated and untreated sites separately.
Next assessment focus
Record the number of lesions and aggregate exposure per session to assess the feasibility and safety of treating multiple lesions.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
10Early symptom changesHistorical observation

The sponsor reports early changes in selected symptoms and functions.

What was recorded
Historical records describe changes such as reduced bleeding, less pain, or improvement in a local function.
How the evidence supports this feature
Human case H1 documented reduced pain after local bleeding stopped, while case H5 recorded changes in breathing, pain, sleep and appetite. In canine oral sarcoma case P4, the record also tracked eating and activity. These observations identify specific symptoms and functions worth measuring from baseline through follow-up alongside imaging findings.
Next assessment focus
Track pain, bleeding, eating and breathing at standard follow-up points to assess the size and duration of symptom changes.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
11Experience across operatorsProcedural record

The original tables present reproducibility across operators as a research feature.

What was recorded
Cases were recorded at different institutions by operators with varying prior experience.
How the evidence supports this feature
The procedural records document use by operators at different institutions. The study protocol provides a common framework for recording visible distribution and for reviewing follow-up images. Together they support a practical approach to comparing consistency across teams using the same observations and review criteria.
Next assessment focus
Compare how consistently teams carry out the procedure under a common training and imaging workflow.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1
12Use of standard delivery instrumentsProcedural record

The original tables describe standard needles and syringes for the delivery step.

What was recorded
Historical procedural records document standard delivery instruments.
How the evidence supports this feature
The procedural records describe delivery using standard needles and syringes. The study pairs those instruments with imaging or direct visualization appropriate to the lesion, and specifies containment and safety assessments. The records support use of standard instruments for the delivery step, with the study workflow defining how teams evaluate that step.
Next assessment focus
Use standardized procedure records and imaging review to assess how consistently teams can carry out the study workflow.
IB §2.3 / Table 2-1 · Technical rationale §4.2 / Table 4-1

How the source connects the features

  • Local changes and early bleeding observations14
  • Spatial containment236
  • Intraprocedural assessment56
  • Repeat-session feasibility71112

Features 8–10 connect the planning of complex lesions with follow-up measures for pain, bleeding and other symptoms.

LONG-TERM RESEARCH HYPOTHESIS

How we aim to make some cancers manageable as chronic diseases

Schematic curves of local tumor burden over time. The gray curve shows the natural course. The red dashed curve shows regrowth after incomplete clearance. The blue curve illustrates the goal of keeping the treated site below the symptom threshold over time.
The shaded area marks the proposed control zone below the symptom threshold. The curves illustrate the research concept and contain no clinical measurements. View full-size figure
  1. Limit exposure to the target

    The sharp reaction boundaries recorded in experiments provide the basis for testing image-guided containment in patients.

    Technical features 236
  2. Build on local tumor control

    Local tissue changes have been recorded in the treated area. Follow-up imaging assesses tissue viability and helps evaluate the proposed role of microvascular effects.

    Technical features 145
  3. Manage new or residual lesions over time

    Repeat local treatment could allow accessible residual or new lesions to be managed over time, alongside other treatments when appropriate.

    Technical features 7891112
  4. Make long-term cancer control possible

    The long-term goal is to sustain control of lesions and symptoms, reduce the threat cancer poses to life and help some patients live longer with manageable disease.

    Technical features 10

This is the program’s long-term development hypothesis. CDX-101 remains investigational. See the Phase 1 endpoints

Local oxidative action and thermal ablation

Investigational CDX-101 uses a local chemical oxidation mechanism. Thermal ablation modalities use tissue temperature change. This distinction concerns the mechanism. The project sources do not establish superior safety or efficacy versus thermal ablation.

IB v1.0 §2.4, mechanism and procedure comparison

PHASE 1 STUDY DESIGN

How delivery is studied and what Phase 1 measures

The proposed research uses imaging to locate the target lesion and confirm that the needle tip is within it. The study evaluates local delivery of the golden-yellow chlorine dioxide solution and monitors the visible distribution relative to the lesion boundary. The protocol also allows direct visualization for appropriately exposed lesions.

Primary · Safety and containment
Assess tolerability, dose-limiting toxicity and other adverse events. Record imaging-visible spread outside the lesion, deliveries stopped for safety and any injury to non-target tissue.
Secondary · Local response
Assess complete non-viable response (CNVR) on follow-up imaging, along with the extent of necrosis and the duration of local control.
Exploratory · Perfusion
Study changes in blood flow in the treated area. These measurements help investigate the secondary-ischemia hypothesis.

Visible distribution during delivery measures containment. Follow-up imaging evaluates whether tissue later became non-viable.

Review the Phase 1 study plan

IMAGE-GUIDED INTRATUMORAL DELIVERY SIMULATED ULTRASOUND GOLDEN ClO₂ SOLUTION TARGET LESION NEEDLE TIP CONCEPTUAL SCHEMATIC
The illustration shows a syringe with golden-yellow chlorine dioxide solution and a needle tip within a target lesion. The simulated ultrasound inset illustrates scattered bright echoes around the needle tip. The contours and highlighted area are schematic.